Insider Selling: Nu Skin Enterprises, Inc. (NUS) Director Sells $287,845.36 in Stock
Nu Skin Enterprises, Inc. (NYSE:NUS) Director Daniel W. Campbell sold 4,607 shares of the business’s stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $62.48, for a total value of $287,845.36. Following the sale, the director now directly owns 63,753 shares of the company’s stock, valued at approximately $3,983,287.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Nu Skin Enterprises, Inc. (NYSE:NUS) opened at 61.77 on Thursday. Nu Skin Enterprises, Inc. has a 1-year low of $46.35 and a 1-year high of $66.04. The stock has a 50 day moving average price of $60.58 and a 200-day moving average price of $57.66. The company has a market cap of $3.27 billion, a price-to-earnings ratio of 20.66 and a beta of 1.37.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Wednesday, August 2nd. The company reported $0.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.69 by $0.08. The business had revenue of $550.10 million during the quarter, compared to analyst estimates of $548.09 million. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. The company’s revenue was down 8.4% on a year-over-year basis. During the same quarter last year, the business posted $0.79 EPS. On average, equities research analysts forecast that Nu Skin Enterprises, Inc. will post $3.23 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 13th. Shareholders of record on Friday, August 25th were paid a dividend of $0.36 per share. The ex-dividend date was Wednesday, August 23rd. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.33%. Nu Skin Enterprises’s payout ratio is currently 48.81%.
TRADEMARK VIOLATION WARNING: This news story was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/09/14/insider-selling-nu-skin-enterprises-inc-nus-director-sells-287845-36-in-stock.html.
Several analysts have issued reports on NUS shares. Stifel Nicolaus set a $50.00 price target on Nu Skin Enterprises and gave the company a “sell” rating in a report on Thursday, August 3rd. Pivotal Research reissued a “buy” rating and set a $80.00 price target (up previously from $65.00) on shares of Nu Skin Enterprises in a report on Thursday, June 22nd. ValuEngine raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Deutsche Bank AG boosted their price target on Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a report on Wednesday, June 21st. Finally, Zacks Investment Research raised Nu Skin Enterprises from a “sell” rating to a “hold” rating in a report on Wednesday, July 5th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the stock. Nu Skin Enterprises presently has an average rating of “Hold” and a consensus target price of $62.88.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. raised its stake in shares of Nu Skin Enterprises by 21,593.4% during the 1st quarter. BlackRock Inc. now owns 6,683,531 shares of the company’s stock valued at $371,201,000 after buying an additional 6,652,722 shares during the last quarter. Credit Suisse AG raised its stake in shares of Nu Skin Enterprises by 64.9% during the 1st quarter. Credit Suisse AG now owns 122,216 shares of the company’s stock valued at $6,788,000 after buying an additional 48,082 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of Nu Skin Enterprises by 22.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 885,257 shares of the company’s stock valued at $55,628,000 after buying an additional 160,495 shares during the last quarter. Liberty Mutual Group Asset Management Inc. purchased a new position in shares of Nu Skin Enterprises during the 1st quarter valued at about $1,235,000. Finally, Karp Capital Management Corp purchased a new position in shares of Nu Skin Enterprises during the 1st quarter valued at about $1,678,000. Institutional investors and hedge funds own 79.25% of the company’s stock.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Stock Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related stocks with our FREE daily email newsletter.